| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.98M | 61.41M | 70.61M | 72.78M | 59.25M | 47.98M |
| Gross Profit | 21.18M | 22.22M | 26.89M | 28.64M | 20.19M | 13.01M |
| EBITDA | -6.43M | -4.42M | 3.45M | 6.03M | 5.90M | 288.00K |
| Net Income | -11.19M | -10.69M | -2.17M | 1.63M | 16.22M | -11.69M |
Balance Sheet | ||||||
| Total Assets | 74.99M | 80.69M | 97.26M | 102.44M | 103.94M | 73.54M |
| Cash, Cash Equivalents and Short-Term Investments | 6.79M | 10.56M | 9.46M | 9.06M | 25.05M | 18.12M |
| Total Debt | 5.34M | 6.49M | 10.10M | 9.21M | 9.19M | 2.58M |
| Total Liabilities | 16.36M | 18.50M | 25.43M | 30.67M | 35.14M | 17.38M |
| Stockholders Equity | 58.62M | 62.18M | 71.83M | 71.77M | 68.80M | 52.39M |
Cash Flow | ||||||
| Free Cash Flow | 589.00K | 5.58M | -2.39M | -10.89M | -3.97M | -3.90M |
| Operating Cash Flow | 1.94M | 6.60M | -449.00K | -5.50M | -2.05M | -2.81M |
| Investing Cash Flow | -1.78M | -768.00K | 570.00K | -8.63M | 7.81M | -636.00K |
| Financing Cash Flow | -4.08M | -4.29M | -1.35M | -2.92M | -674.00K | -1.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £620.94M | 23.96 | 8.49% | 2.09% | 0.49% | 61.73% | |
74 Outperform | £2.75B | 32.78 | 9.15% | 2.12% | 3.15% | -13.57% | |
70 Neutral | £85.23M | 18.95 | 9.34% | ― | 7.36% | 31.93% | |
67 Neutral | £193.78M | 51.87 | 3.13% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | £85.99M | -7.71 | -16.64% | ― | -7.35% | -222.10% | |
39 Underperform | £43.85M | -38.46 | -17.36% | ― | -14.81% | -1362.50% |
Xaar reported a like-for-like revenue increase of 16.6% for 2025 to £60.3 million, driven by strong 28.9% growth in printhead sales and stable performance in its core ceramics segment, while newer products and markets such as jewellery wax provided additional momentum. Improved gross margins from higher volumes and cost control mean adjusted full-year profits are expected to be slightly ahead of expectations, though net cash declined to about £4.8 million after £3.1 million of capital investment; the company highlighted that its differentiated fluid-deposition technology is now contributing to revenues beyond ceramics and expressed optimism about the scale of future opportunities, bolstered by the appointment of Berenberg and Singer Capital Markets as joint corporate brokers.
The most recent analyst rating on (GB:XAR) stock is a Hold with a £105.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.
Xaar plc has confirmed that its issued share capital comprises 79,816,895 ordinary shares of 10 pence each, with no shares held in treasury, establishing the total number of voting rights in the company as at 31 December 2025. The company noted that this figure, which includes shares held within trustee and ESOP structures, should be used by shareholders as the reference point for determining whether they are required to disclose holdings or changes in their interests under UK financial transparency rules, providing clarity for investors and regulators on Xaar’s capital and voting structure.
The most recent analyst rating on (GB:XAR) stock is a Hold with a £124.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.
Xaar plc announced that its issued share capital comprises 79,783,945 ordinary shares, with no shares held in treasury. This announcement is in accordance with the FCA’s Disclosure and Transparency Rules, and the total voting rights figure will be used by shareholders to assess their interests in the company.
The most recent analyst rating on (GB:XAR) stock is a Hold with a £116.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.
Xaar plc announced a transaction involving the lapse of share options under the Xaar 2017 Sharesave Plan by Graham Tweedale, the Chief Operating Officer and Person Discharging Managerial Responsibilities. This transaction, involving 3,857 shares at a price of £1.40 each, was conducted outside a trading venue and reflects the company’s adherence to the UK Market Abuse Regulation, ensuring transparency and regulatory compliance.
The most recent analyst rating on (GB:XAR) stock is a Hold with a £116.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.
Xaar plc has announced its total voting rights, with the company’s issued share capital consisting of 79,783,945 ordinary shares as of October 31, 2025. This figure is crucial for shareholders to determine their required notifications under the FCA’s Disclosure and Transparency Rules, impacting how stakeholders manage their interests in the company.
The most recent analyst rating on (GB:XAR) stock is a Hold with a £126.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.